SummaryBehçet's disease is a multi-systemic inflammatory disorder of unknown cause. Most abnormalities have been associated with endothelial injury caused by vasculitis. Thrombosis occurs in about 25% of patients, although the mechanism is unknown. The objective of this study was to evaluate the protein C activation system in Behçet's disease and its correlation with venous thromboembolism (VTE). Thirty-nine patients (12 with VTE) and 78 age-and sex-matched controls were included in the study, and levels of protein C, protein S, activated protein C (APC), protein C inhibitor (PCI), soluble thrombomodulin (TM), antithrombin (AT), a 1 -antitrypsin, fibrinogen, factor VIII, von Willebrand factor (VWF) and C-reactive protein (CRP) were measured. APC and TM levels were significantly lower in patients than in controls, whereas protein S, AT, a 1 -antitrypsin, fibrinogen, factor VIII, VWF and CRP levels were significantly higher in patients than in controls. APC, PCI and TM levels were lower in patients with VTE (0AE65 ± 0AE19 ng/ml, 86% ± 22% and 15AE5 ± 7AE1 ng/ml respectively) than in those without VTE (0AE78 ± 0AE17 ng/ml, 100% ± 15% and 22AE1 ± 15AE3 ng/ml) (P < 0AE05). In patients, APC levels below 0AE75 ng/ml (10th percentile of the control group) increased the risk of VTE about fivefold (odds ratio ¼ 5AE1; 95% confidence interval ¼ 1AE1-23AE4). These results show that reduced APC levels are associated with the high incidence of VTE in Behçet's disease.